Convalescent plasma as additional therapies in COVID-19 patients
Indonesian Journal of Blood And Transfusion · 2023
DOI: 10.51559/80ht3735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Journal of Blood And Transfusion, 2023. Verfasst von Pratiwi Endang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Corona Virus 2 (SARS-CoV-2) is a new virus who can make an infectious disease that we called Corona Virus Disease 2019 (COVID-19). The main symptoms manifest in the respiratory tract such as fever, cough, and shortness of breath. This disease spread very fast to various continents in a short time. The use of convalescent plasma as additional therapy for COVID-19 patients based on the previous cases like SARS, Ebola, MERS. A lot of research has been done to find the good therapy for patients. One of the approved treatments by WHO is the administration of COVID convalescent plasma (CCP), as additional therapy, to prevent cytokine storms and to increase life expectancy at COVID-19 patients in Indonesia. Plasma from healthy patients after having cured from COVID-19 infection, who has many Immunoglobulin G, processed by plasmapheresis. This review explained 299 plasma convalescent donors in the Jakarta Blood Center, Red Cross Indonesia. While for the efficacy of patients in the hospital there is no data that we can report. Some clinicians suggest that convalescent plasma should be administered immediately after infection, before the seventh day.
Zitieren
APA
Endang, P., & Saptuti, C. (2023). Convalescent plasma as additional therapies in COVID-19 patients. Indonesian Journal of Blood And Transfusion. https://doi.org/10.51559/80ht3735
Vancouver
Endang P, Saptuti C. Convalescent plasma as additional therapies in COVID-19 patients. Indonesian Journal of Blood And Transfusion. 2023. doi:10.51559/80ht3735
BibTeX
@article{Endang2023,
author = {Endang, Pratiwi and Saptuti, Chunaeni},
title = {Convalescent plasma as additional therapies in COVID-19 patients},
journal = {Indonesian Journal of Blood And Transfusion},
year = {2023},
doi = {10.51559/80ht3735}
}
EUVIMED